Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycograb in AIDS-Associated Cryptococcal Meningitis
NCT00324025Phase 2Terminated
- Sponsor
- Novartis
- Start
- Mar 2007
- Primary completion
- Sep 2007
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cryptococcal meningitis comparing Mycograb Arm with Placebo Arm (2 arms). Primary endpoint: Proportion of patients cured at 14 days. Started Mar 2007; status: terminated.
02
Drugs
efungumab
03
Conditions
cryptococcal meningitis
Beyond the preview
Go deeper on NCT00324025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00324025.